Novalead Pharma recently discovered that 42 existing drugs can be used to treat coronavirus patients at different stages of the infection.
The company’s chief executive Supreet Deshpande said, “ The major advantage with this approach is that the drugs being approved are already proved to be safe for humans, are being actively manufactured and therefore can be immediately put to use in a very short time,”
The company deployed its computational technology to identify drugs which may be effective against the SARS- Cov2 and in minimizing the effect on human body.
“The fight against COVID-19 is a race against time and we are deploying whole of our computational infrastructure and technology platform armed with artificial intelligence (AI) and use machine learning (ML) techniques, along with intensive statistical modeling and simulations,” Deshpande said.
“We have completed three phases of rational computational screenings and our discoveries so far include drugs that show promise as effective treatment either by directly attacking the virus proteins or by empowering the human proteins to minimise its spread,” the company’s head of research Sudhir Kulkarni said.
In the past the company has helped in developing drugs for diabetes and psoriasis.